CIK 0001528115
- Non-accelerated filer
- Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275414423
- Phone
- +1 650-822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,106 shares at $6.02 ($6,658)
- 4 Open-market buy Director bought 3,200 shares at $5.00 ($16,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,200 shares at $4.83 ($15,459)
- 4 Open-market buy Director bought 3,200 shares at $4.68 ($14,982)
- 4 Open-market buy Director bought 3,200 shares at $6.07 ($19,411)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 39,000 shares (grant or award)
- 4 Grant or award EVP & CHIEF SCIENTIFIC OFFICER acquired 39,000 shares (grant or award)
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 2,593 shares at $5.53 ($14,339)
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 2,604 shares at $5.51 ($14,348)
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 1,951 shares at $5.48 ($10,691)
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 1,349 shares at $5.53 ($7,460)
- 4 Open-market sale PRESIDENT AND CEO sold 5,782 shares at $5.54 ($32,032)
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,809 shares at $5.54 ($10,022)
Page 5 of 11 · 206 filings